Age

Visit number vs Interleukin-6 soluble receptor
N Mean StdDev Median Min Max Unknown Total
Baseline 317 43,528.7 ± 12,061.4 42,491.9 22,760.5 107,271.3 1 318
Follow-up 295 42,149.5 ± 11,869.9 41,118.2 22,477.1 103,644.5 6 301
Treatment Arm vs Interleukin-6 soluble receptor
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 43,528.7 ± 12,061.4 42,491.9 22,760.5 107,271.3 1 318
Healthy Lifestyles and Sleep Education - control arm (HLSE) 106 42,532.2 ± 11,785.7 40,387.4 25,641.1 107,271.3 - 106
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 105 44,141.7 ± 12,371.9 43,949.4 22,760.5 79,836.1 1 106
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 106 43,917.9 ± 12,073.9 43,124.7 23,150.9 92,239.8 - 106
Treatment Arm vs Interleukin-6 soluble receptor
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 295 42,149.5 ± 11,869.9 41,118.2 22,477.1 103,644.5 6 301
Healthy Lifestyles and Sleep Education - control arm (HLSE) 99 41,014.9 ± 11,396.0 40,118.2 23,392.9 99,602.0 1 100
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 98 42,735.5 ± 12,235.6 40,767.2 24,042.4 80,130.2 3 101
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 98 42,709.7 ± 12,006.2 42,395.0 22,477.1 103,644.5 2 100
Age category vs Interleukin-6 soluble receptor
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 43,528.7 ± 12,061.4 42,491.9 22,760.5 107,271.3 1 318
45-54 years 53 44,456.5 ± 12,765.6 43,293.3 26,461.8 107,271.3 - 53
55-64 years 139 43,564.2 ± 12,443.3 42,905.9 23,682.0 92,239.8 - 139
65 years or older 125 43,095.8 ± 11,380.7 40,995.7 22,760.5 79,836.1 1 126
Age category vs Interleukin-6 soluble receptor
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 295 42,149.5 ± 11,869.9 41,118.2 22,477.1 103,644.5 5 300
45-54 years 46 41,522.4 ± 12,055.2 42,223.4 25,090.5 99,602.0 3 49
55-64 years 125 42,531.3 ± 12,634.7 41,248.2 22,477.1 103,644.5 2 127
65 years or older 124 41,997.2 ± 11,061.4 40,326.0 23,794.6 71,211.7 - 124
Gender of the participant vs Interleukin-6 soluble receptor
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 43,528.7 ± 12,061.4 42,491.9 22,760.5 107,271.3 1 318
Female 83 43,706.1 ± 10,327.5 43,361.7 22,760.5 67,328.1 1 84
Male 234 43,465.8 ± 12,639.2 42,428.3 23,150.9 107,271.3 - 234
Gender of the participant vs Interleukin-6 soluble receptor
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 295 42,149.5 ± 11,869.9 41,118.2 22,477.1 103,644.5 6 301
Female 78 42,263.7 ± 10,422.0 41,315.9 24,042.4 71,211.7 1 79
Male 217 42,108.5 ± 12,371.2 40,913.6 22,477.1 103,644.5 5 222
Race of the participant vs Interleukin-6 soluble receptor
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 316 43,488.8 ± 12,059.6 42,431.1 22,760.5 107,271.3 1 317
White 256 44,318.5 ± 12,395.8 43,124.7 23,150.9 107,271.3 - 256
American Indian or Alaskan Native 2 34,951.0 ± 5,964.6 34,951.0 30,733.3 39,168.6 - 2
Black or African American 42 39,000.2 ± 10,582.2 39,694.6 22,760.5 65,616.8 1 43
Asian 6 43,227.9 ± 6,631.9 43,089.3 33,351.6 53,784.1 - 6
Native Hawaiian or other Pacific islander 1 38,806.1 - 38,806.1 38,806.1 38,806.1 - 1
Other 4 42,769.8 ± 9,637.1 43,772.0 31,651.6 51,883.5 - 4
Multiple 5 43,954.2 ± 8,808.3 41,035.0 32,213.3 52,956.0 - 5
Race of the participant vs Interleukin-6 soluble receptor
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 294 42,095.1 ± 11,853.3 41,110.9 22,477.1 103,644.5 5 299
White 238 43,031.7 ± 12,209.1 41,436.4 23,794.6 103,644.5 3 241
American Indian or Alaskan Native 2 34,432.1 ± 4,646.6 34,432.1 31,146.5 37,717.7 - 2
Black or African American 39 36,893.7 ± 9,762.3 35,638.0 22,477.1 71,211.7 2 41
Asian 6 44,498.9 ± 4,901.5 45,264.7 37,138.0 51,576.3 - 6
Native Hawaiian or other Pacific islander 1 41,816.4 - 41,816.4 41,816.4 41,816.4 - 1
Other 3 38,810.2 ± 9,402.9 35,696.0 31,359.5 49,375.1 - 3
Multiple 5 40,289.6 ± 10,416.8 43,375.3 23,392.9 51,474.7 - 5